ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: Monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression
- Annick D. Van Den Abbeele
- , Constantine Gatsonis
- , Daniel J. De Vries
- , Yulia Melenevsky
- , Agnieszka Szot-Barnes
- , Jeffrey T. Yap
- , Andrew K. Godwin
- , Lori Rink
- , Min Huang
- , Meridith Blevins
- , Jo Rean Sicks
- , Burton Eisenberg
- , Barry A. Siegel
Research output: Contribution to journal › Article › peer-review
45
Link opens in a new tab
Scopus
citations